The absolute monocyte and lymphocyte prognostic index for patients with diffuse large B-cell lymphoma who receive R-chop

Clinical Lymphoma, Myeloma and Leukemia

Volumn 13, Issue 1, 2013, Pages 15-18

  Batty, Nicolas ^a   Ghonimi, Elham ^b   Feng, Lei ^b   Fayad, Luis ^b   Younes, Anas ^b   Rodriguez, Maria Alma ^b   Romaguera, Jorge Enrique ^b   McLaughlin, Peter ^b   Samaniego, Felipe ^b   Kwak, Larry W ^b   Hagemeister, Fredrick B ^b  

^a ROSWELL PARK CANCER INSTITUTE   (United States)

^b UNIVERSITY OF TEXAS MD ANDERSON CANCER CENTER   (United States)

Author keywords

International prognostic factors index; Large cell lymphoma; Prognostic factors; R CHOP chemotherapy

Indexed keywords

CYCLOPHOSPHAMIDE; DOXORUBICIN; PREDNISONE; RITUXIMAB; VINCRISTINE SULFATE;

ABSOLUTE MONOCYTE AND LYMPHOCYTE PROGNOSTIC INDEX; ADULT; AGED; ARTICLE; CANCER COMBINATION CHEMOTHERAPY; CANCER PATIENT; CANCER PROGNOSIS; CANCER RADIOTHERAPY; CANCER RISK; CANCER SURVIVAL; CELL COUNT; FEMALE; FOLLOW UP; HIGH RISK POPULATION; HUMAN; INTERNATIONAL PROGNOSTIC INDEX; LARGE CELL LYMPHOMA; LYMPHOCYTE COUNT; MAJOR CLINICAL STUDY; MALE; MONOCYTE; MONOCYTE COUNT; MULTIMODALITY CANCER THERAPY; NAMED INVENTORIES, QUESTIONNAIRES AND RATING SCALES; OVERALL SURVIVAL; PROGRESSION FREE SURVIVAL; RETROSPECTIVE STUDY;

EID: 84873323278     PISSN: 21522650     EISSN: 21522669     Source Type: Journal    
DOI: 10.1016/j.clml.2012.09.009     Document Type: Article

References (21)

1. R.A. Wilcox, K. Ristow, T.M. Habermann The absolute monocyte and lymphocyte prognostic score predicts survival and identifies high-risk patients in diffuse large-B-cell lymphoma Leukemia 25 2011 1502 1509
2. G. Lenz, G. Wright, S.S. Dave Lymphoma/Leukemia Molecular Profiling Project Stromal gene signatures in large-B-cell lymphomas N Engl J Med 22 2008 2313
3. S.M. Ansell, M. Stenson, T.M. Habermann CD4+ T-cell immune response to large B-cell non-Hodgkin's lymphoma predicts patient outcome J Clin Oncol 19 2001 720 726
4. D.I. Gabrilovich, S. Nagaraj Myeloid-derived suppressor cells as regulators of the immune system Nat Rev Immunol 3 2009 162 174
5. F. Donskov, H. von der Maase Impact of immune parameters on long-term survival in metastatic renal cell carcinoma J Clin Oncol 24 2006 1997 2005
6. Y. Takasaki, M. Iwanaga, K. Tsukasaki Impact of visceral involvements and blood cell count abnormalities on survival in adult T-cell leukemia/lymphoma (ATLL) Leuk Res 31 2007 751 757
7. R.A. Wilcox, A.L. Feldman, D.A. Wada B7-H1 (PD-L1, CD274) suppresses host immunity in T-cell lymphoproliferative disorders Wilcox RA Blood 10 2009 2149
8. M.A. Venneri, M. De Palma, M. Ponzoni Identification of proangiogenic TIE2-expressing monocytes (TEMs) in human peripheral blood and cancer Blood 109 2007 5276 5285
9. A.J. Novak, D.M. Grote, M. Stenson Expression of BLyS and its receptors in B-cell non-Hodgkin lymphoma: correlation with disease activity and patient outcome Blood 104 2004 2247 2253
10. R.A. Wilcox, D.A. Wada, S.C. Ziesmer Monocytes promote tumor cell survival in T-cell lymphoproliferative disorders and are impaired in their ability to differentiate into mature dendritic cells Blood 114 2009 2936 2944
11. M. Seiffert, A. Schulz, S. Ohl Soluble CD14 is a novel monocyte-derived survival factor for chronic lymphocytic leukemia cells, which is induced by CLL cells in vitro and present at abnormally high levels in vivo Blood 116 2010 4223 4230
12. W.H. Wilson, F.J. Hernandez-Ilizaliturri, K. Dunleavy Novel disease targets and management approaches for diffuse large B-cell lymphoma Leuk Lymphoma 51 suppl 1 2010 1 10
13. L.F. Porrata, K. Ristow, T.M. Habermann Absolute monocyte/lymphocyte count prognostic score is independent of immunohistochemically determined cell of origin in predicting survival in diffuse large B-cell lymphoma Leuk Lymphoma 53 2012 2159 2651
14. L. Shivakumar, S. Ansell Targeting B-lymphocyte stimulator/B-cell activating factor and a proliferation-inducing ligand in hematologic malignancies Clin Lymph Myeloma 7 2006 106 108
15. G.J. Weiner Rituximab: mechanism of action Semin Hematol 47 2010 115 123
16. M.K. Song, J.S. Chung, Y.M. Seol Influence of low absolute lymphocyte count of patients with nongerminal center type diffuse large B-cell lymphoma with R-CHOP therapy Ann Oncol 21 2010 140 144
17. R.A. Wilcox, K. Ristow, T.M. Habermann The absolute monocyte count is associated with overall survival in patients newly diagnosed with follicular lymphoma Leuk Lymphoma 53 2012 575 580
18. R.A. Wilcox, N. Neil Kay, G. Timothy In patients newly diagnosed with chronic lymphocytic leukemia the absolute monocyte count at presentation is directly associated with disease progression independently from Rai staging or cytogenetics ASH Annual Meeting Abstracts 2835 118 2011 2835
19. J.S. Ko, R.M. Bukowski, J.H. Fincke Myeloid-derived suppressor cells: a novel therapeutic target Curr Oncol Rep 11 2009 87 93
20. N. Mounier, J. Briere, C. Gisselbrecht Rituximab plus CHOP (R-CHOP) overcomes bcl-2-associated resistance to chemotherapy in elderly patients with diffuse large B-cell lymphoma (DLBCL) Blood 11 2003 4279
21. G. Lenz, G. Wright, S.S. Dave Stromal gene signatures in large-B-cell lymphomas N Engl J Med 359 2008 2313 2323